- Report
- August 2022
- 200 Pages
Global
From €3964EUR$4,450USD£3,382GBP
- Report
- March 2022
- 217 Pages
Global
From €3964EUR$4,450USD£3,382GBP
- Report
- December 2021
- 191 Pages
Global
From €3964EUR$4,450USD£3,382GBP
- Report
- August 2021
- 177 Pages
Global
From €3964EUR$4,450USD£3,382GBP
- Report
- June 2019
- 153 Pages
Global
From €3964EUR$4,450USD£3,382GBP
- Report
- February 2024
- 111 Pages
Global
From €4231EUR$4,750USD£3,610GBP
- Report
- February 2024
- 120 Pages
Global
From €4231EUR$4,750USD£3,610GBP
- Report
- June 2022
- 120 Pages
Global
From €2227EUR$2,500USD£1,900GBP
- Report
- June 2024
- 200 Pages
Global
From €7081EUR$7,950USD£6,042GBP
- Report
- July 2022
- 100 Pages
Global
From €2450EUR$2,750USD£2,090GBP
- Report
- October 2023
- 190 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP
- Report
- December 2024
- 80 Pages
France
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP
- Report
- December 2024
- 80 Pages
India
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP
- Report
- December 2024
- 87 Pages
Spain
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP
- Report
- December 2024
- 85 Pages
India
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP
- Report
- December 2024
- 85 Pages
Saudi Arabia
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP
- Report
- September 2024
- 80 Pages
Japan
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP
- Report
- May 2024
- 186 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP
- Report
- April 2024
- 180 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more